Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum-Reference-Cited by-同舟云学术

Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum

Published:2011-07-13 Issue:3 Volume:36 Page:151-158
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Milner Erin,Sousa Jason,Pybus Brandon,Melendez Victor,Gardner Sean,Grauer Kristina,Moon Jay,Carroll Dustin,Auschwitz Jennifer,Gettayacamin Montip,Lee Patricia,Leed Susan,McCalmont William,Norval Suzanne,Tungtaeng Anchalee,Zeng Qiang,Kozar Michael,Read Kevin D.,Li Qigui,Dow Geoffrey

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s13318-011-0047-8.pdf

Reference12 articles.

1. Briand V, Bottero J, Noël H, Masse V, Cordel H, Guerra J, Kossou H, Fayomi B, Ayemonna P, Fievet N, Massougbodji A, Cot M (2009) Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. J Infect Dis 200:991–1001

2. Cairns M, Gosling R, Carneiro I, Gesase S, Mosha JF, Hashim R, Kaur H, Lemnge M, Mosha FW, Greenwood B, Chandramohan D (2010) Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants. PLoS One 5:e9467

3. Centers for Disease Control (2008) CDC health information for international travel. Elsevier, Atlanta

4. Dow GS, Heady TN, Bhattacharjee AK, Caridha D, Gerena L, Gettayacamin M, Lanteri CA, Obaldia N 3rd, Roncal N, Shearer T, Smith PL, Tungtaeng A, Wolf L, Cabezas M, Yourick D, Smith KS (2006) Utility of alkylaminoquinolinyl methanols as new antimalarial drugs. Antimicrob Agents Chemother 50:4132–4143

5. Dow GS, Magill AJ, Ohrt C (2008) Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki. Ther Clin Risk Manag 4:803–819

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assay validation and determination of in vitro binding of mefloquine to plasma proteins from clinically normal and FIP-affected cats;PLOS ONE;2020-08-05

2. Quinoline and quinolone dimers and their biological activities: An overview;European Journal of Medicinal Chemistry;2019-01

3. Quinoline hybrids and their antiplasmodial and antimalarial activities;European Journal of Medicinal Chemistry;2017-10

4. A small-fish model for behavioral-toxicological screening of new antimalarial drugs: a comparison between erythro- and threo-mefloquine;BMC Research Notes;2015-04-02

5. Pharmacokinetic considerations in the repositioning of mefloquine for treatment of progressive multifocal leukoencephalopathy;Clinical Neurology and Neurosurgery;2012-10